Tenaya Therapeutics Inc. (TNYA) NASDAQ

$5.29 0.13 (2.52%)

Market Cap: $405.14M

As of 03/28/24 09:30 AM EDT. Market open.

(TNYA)

Tenaya Therapeutics Inc. (TNYA)
NASDAQ

$5.29
0.13 (2.52%)

Market Cap: $405.14M

As of 03/28/24 09:30 AM EDT. Market open.

Add to Portfolio

tenaya therapeutics is a privately-held biopharmaceutical company backed by the column group. the company was founded in 2016 by world-leading scientists from the gladstone institute’s cardiovascular division and the university of texas southwestern medical center. tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies ... read more

tenaya therapeutics is a privately-held biopharmaceutical company backed by the column group. the company was founded in 2016 by world-leading scientists from the gladstone institute’s cardiovascular division and the university of texas southwestern medical center. tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration. tenaya has a lead gene therapy program focused on in vivo reprogramming of cardiac fibroblasts to cardiomyocytes to regenerate heart tissue, and additional programs focused on cardiomyopathies. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
149
URL
Address
.
PRICE CHART FOR TENAYA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.29
Previous Close
$5.16
Days Range
$4.80 - $5.28
52 week range
$1.66 - $8.09
Volume
11,400
Avg. Volume (30 days)
696,636
Market Cap
$405.14M
Dividend Yield
-
P/E
-
Shares Outstanding
78,516,142
Open
$5.29
Previous Close
$5.16
Days Range
$4.80 - $5.28
52 week range
$1.66 - $8.09
Volume
11,400
Avg. Volume (30 days)
696,636
Market Cap
$405.14M
Dividend Yield
-
P/E
-
Shares Outstanding
78,516,142
FINANCIAL STATEMENTS FOR TENAYA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TENAYA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hoey TimothyChief Scientific OfficerMar 05, 2024 Sale$7.003,30023,101245,346Mar 06, 2024, 06:45 PM
Hoey TimothyChief Scientific OfficerFeb 20, 2024 Sale$5.346,56935,046236,346Feb 21, 2024, 06:05 PM
Hoey TimothyChief Scientific OfficerFeb 16, 2024 Sale$5.864,68127,431242,715Feb 16, 2024, 08:37 PM
Tingley WhittemoreChief Medical OfficerFeb 16, 2024 Sale$5.866,50038,09073,534Feb 16, 2024, 08:35 PM
PATTERSON LEONE DChief Fin. and Bus. OfficerFeb 16, 2024 Sale$5.865,20130,47860,755Feb 16, 2024, 08:32 PM
Ali FarazChief Executive OfficerFeb 16, 2024 Sale$5.866,35837,258113,079Feb 16, 2024, 08:30 PM
COLUMN GROUP III GP, LP10% OwnerFeb 12, 2024 Buy$4.502,222,2229,999,99913,599,275Feb 14, 2024, 04:15 PM
GOEDDEL DAVID VDirectorFeb 12, 2024 Buy$4.502,222,2229,999,99913,599,275Feb 14, 2024, 04:12 PM
Hoey TimothyChief Scientific OfficerAug 29, 2023 Sale$4.267,24330,855247,396Aug 29, 2023, 06:59 PM
Hoey TimothyChief Scientific OfficerAug 16, 2023 Sale$3.814,00715,267254,639Aug 18, 2023, 06:34 PM
Tingley WhittemoreChief Medical OfficerAug 16, 2023 Sale$3.815,56321,19576,437Aug 18, 2023, 06:33 PM
PATTERSON LEONE DChief Fin. and Bus. OfficerAug 16, 2023 Sale$3.814,45216,96264,542Aug 18, 2023, 06:31 PM
Ali FarazChief Executive OfficerAug 16, 2023 Sale$3.815,56321,195119,437Aug 18, 2023, 06:31 PM
COLUMN GROUP III GP, LP10% OwnerMar 10, 2023 Buy$2.606,77917,59611,377,053Mar 14, 2023, 04:12 PM
GOEDDEL DAVID VDirectorMar 10, 2023 Buy$2.606,77917,59611,377,053Mar 14, 2023, 04:09 PM
COLUMN GROUP III GP, LP10% OwnerFeb 08, 2023 Buy$2.601,500,0003,900,00011,370,274Feb 10, 2023, 04:32 PM
GOEDDEL DAVID VDirectorFeb 08, 2023 Buy$2.601,500,0003,900,00011,370,274Feb 10, 2023, 04:22 PM
COLUMN GROUP III GP, LP10% OwnerJan 19, 2023 Buy$2.5069,739174,2019,870,274Jan 23, 2023, 04:25 PM
GOEDDEL DAVID VDirectorJan 19, 2023 Buy$2.5069,739174,2019,870,274Jan 23, 2023, 04:21 PM
COLUMN GROUP III GP, LP10% OwnerJan 17, 2023 Buy$2.4949,463123,3959,664,847Jan 19, 2023, 04:18 PM
COLUMN GROUP III GP, LP10% OwnerJan 18, 2023 Buy$2.52135,688341,4329,800,535Jan 19, 2023, 04:18 PM
GOEDDEL DAVID VDirectorJan 18, 2023 Buy$2.52135,688341,4329,800,535Jan 19, 2023, 04:13 PM
GOEDDEL DAVID VDirectorJan 17, 2023 Buy$2.4949,463123,3959,664,847Jan 19, 2023, 04:13 PM
Srivastava DeepakDirectorNov 21, 2022 Buy$2.60230,769599,999372,435Dec 09, 2022, 07:59 PM
Casdin EliDirectorNov 17, 2022 Buy$2.602,492,0426,479,3096,078,860Nov 25, 2022, 07:05 PM
COLUMN GROUP III GP, LP10% OwnerNov 21, 2022 Buy$2.609,615,38424,999,9979,615,384Nov 23, 2022, 04:12 PM
GOEDDEL DAVID VDirectorNov 21, 2022 Buy$2.609,615,38424,999,9979,615,384Nov 23, 2022, 04:11 PM
Hoey TimothyChief Scientific OfficerApr 26, 2022 Sale$10.131,35313,706198,646Apr 28, 2022, 07:57 PM
Casdin Partners Master Fund, L.P.10% OwnerAug 03, 2021 Buy$15.00850,00012,750,0003,224,849Aug 04, 2021, 06:33 PM
Casdin EliDirectorAug 03, 2021 Buy$15.00850,00012,750,0003,224,849Aug 04, 2021, 06:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hoey TimothyChief Scientific Officer03/05/202423,101
Hoey TimothyChief Scientific Officer02/20/202435,046
Hoey TimothyChief Scientific Officer02/16/202427,431
Tingley WhittemoreChief Medical Officer02/16/202438,090
PATTERSON LEONE DChief Fin. and Bus. Officer02/16/202430,478
Ali FarazChief Executive Officer02/16/202437,258
COLUMN GROUP III GP, LP10% Owner02/12/20249,999,999
GOEDDEL DAVID VDirector02/12/20249,999,999
Hoey TimothyChief Scientific Officer08/29/202330,855
Hoey TimothyChief Scientific Officer08/16/202315,267
Tingley WhittemoreChief Medical Officer08/16/202321,195
PATTERSON LEONE DChief Fin. and Bus. Officer08/16/202316,962
Ali FarazChief Executive Officer08/16/202321,195
COLUMN GROUP III GP, LP10% Owner03/10/202317,596
GOEDDEL DAVID VDirector03/10/202317,596
COLUMN GROUP III GP, LP10% Owner02/08/20233,900,000
GOEDDEL DAVID VDirector02/08/20233,900,000
COLUMN GROUP III GP, LP10% Owner01/19/2023174,201
GOEDDEL DAVID VDirector01/19/2023174,201
COLUMN GROUP III GP, LP10% Owner01/17/2023123,395
COLUMN GROUP III GP, LP10% Owner01/18/2023341,432
GOEDDEL DAVID VDirector01/18/2023341,432
GOEDDEL DAVID VDirector01/17/2023123,395
Srivastava DeepakDirector11/21/2022599,999
Casdin EliDirector11/17/20226,479,309
COLUMN GROUP III GP, LP10% Owner11/21/202224,999,997
GOEDDEL DAVID VDirector11/21/202224,999,997
Hoey TimothyChief Scientific Officer04/26/202213,706
Casdin Partners Master Fund, L.P.10% Owner08/03/202112,750,000
Casdin EliDirector08/03/202112,750,000
Load More Insider Transactions
FUNDS WITH A POSITION IN TENAYA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RA CAPITAL MANAGEMENT, L.P.5,507,3470.28%-18.03%Other
BLACKROCK INC.3,786,8240.00031%-19.14%Other
GEODE CAPITAL MANAGEMENT, LLC928,7630.00031%6.36%Other
RENAISSANCE TECHNOLOGIES LLC482,3250.00242%11.24%Other
D. E. SHAW & CO., INC.95,5670.00027%-23.33%Other
BALYASNY ASSET MANAGEMENT L.P.26,2280.00014%ExitedEvent Driven
AQR CAPITAL MANAGEMENT LLC23,3940.00014%58.66%Other
CHANGE IN SHARES OUTSTANDING FOR TENAYA THERAPEUTICS INC
STOCK BUYBACKS FOR TENAYA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.65%
1Q
12/31/2023
06/30/2023
1.37%
2Q
12/31/2023
03/31/2023
1.79%
3Q
12/31/2023
09/30/2022
79.91%
5Q
12/31/2023
06/30/2022
80.15%
6Q
12/31/2023
03/31/2022
80.30%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.65%
1Q
06/30/2023
1.37%
2Q
03/31/2023
1.79%
3Q
09/30/2022
79.91%
5Q
06/30/2022
80.15%
6Q
03/31/2022
80.30%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TENAYA THERAPEUTICS INC
LOADING...